PL1613648T3 - Oczyszczanie peptydów z siary - Google Patents

Oczyszczanie peptydów z siary

Info

Publication number
PL1613648T3
PL1613648T3 PL04719003T PL04719003T PL1613648T3 PL 1613648 T3 PL1613648 T3 PL 1613648T3 PL 04719003 T PL04719003 T PL 04719003T PL 04719003 T PL04719003 T PL 04719003T PL 1613648 T3 PL1613648 T3 PL 1613648T3
Authority
PL
Poland
Prior art keywords
colostrum
peptides
purification
alcohol
rich
Prior art date
Application number
PL04719003T
Other languages
English (en)
Inventor
Jerzy Alexander Georgiades
Antoni Polanowski
Tadeusz Wilusz
Marian L Kruzel
Original Assignee
Regen Therapeutics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0305552A external-priority patent/GB0305552D0/en
Priority claimed from GB0405190A external-priority patent/GB0405190D0/en
Application filed by Regen Therapeutics Plc filed Critical Regen Therapeutics Plc
Publication of PL1613648T3 publication Critical patent/PL1613648T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL04719003T 2003-03-11 2004-03-10 Oczyszczanie peptydów z siary PL1613648T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0305552A GB0305552D0 (en) 2003-03-11 2003-03-11 Purification of peptides
GB0405190A GB0405190D0 (en) 2004-03-08 2004-03-08 Purification of peptides
PCT/GB2004/001014 WO2004081038A1 (en) 2003-03-11 2004-03-10 Purification of peptides from colostrum
EP04719003A EP1613648B1 (en) 2003-03-11 2004-03-10 Purification of peptides from colostrum

Publications (1)

Publication Number Publication Date
PL1613648T3 true PL1613648T3 (pl) 2008-05-30

Family

ID=32992590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04719003T PL1613648T3 (pl) 2003-03-11 2004-03-10 Oczyszczanie peptydów z siary

Country Status (14)

Country Link
US (2) US20070161780A1 (pl)
EP (2) EP1894943A3 (pl)
JP (1) JP2007527368A (pl)
KR (1) KR101089704B1 (pl)
AT (1) ATE380825T1 (pl)
AU (1) AU2004220313B2 (pl)
CA (1) CA2518762A1 (pl)
CY (1) CY1107195T1 (pl)
DE (1) DE602004010636T2 (pl)
ES (1) ES2297398T3 (pl)
IL (1) IL170782A (pl)
NZ (1) NZ542383A (pl)
PL (1) PL1613648T3 (pl)
WO (1) WO2004081038A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
EP1789073A4 (en) * 2004-09-14 2011-06-08 Nexcell Biosciences Inc ISOLATION OF GROWTH AND DIFFERENTIATION FACTORS FROM COLOSTRUM
GB2436328A (en) * 2006-03-22 2007-09-26 Regen Therapeutics Plc Peptide derived from colostrinin
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
EP4019529A1 (en) * 2008-06-27 2022-06-29 MicroSintesis Inc. Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
CA2773277C (en) 2008-09-12 2019-03-26 Nanoko A/S Colostrum composition
US20110098216A1 (en) * 2009-10-22 2011-04-28 Regen Therapeutics Plc Therapeutic uses of colostrinin
US9861666B2 (en) 2013-08-12 2018-01-09 Mansel Griffiths Antiviral methods and compositions comprising probiotic bacterial molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL89987C (pl) * 1954-05-29
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
JPS53107479A (en) * 1977-02-28 1978-09-19 Green Cross Corp:The Preparation of human lysozyme
US4368262A (en) * 1981-03-23 1983-01-11 Research Corporation Diagnostic test for the detection of cancer
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
FR2617049B1 (fr) * 1987-06-26 1990-06-08 Huet Francois Extrait de colostrum, procede pour son obtention et ses utilisations, notamment dans le traitement de l'acne
PL185442B1 (pl) * 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6852685B1 (en) * 1999-08-17 2005-02-08 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
US6500798B1 (en) * 1999-08-17 2002-12-31 Board Of Regents, The University Of Texas System Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
JP2001240599A (ja) * 2000-02-29 2001-09-04 Snow Brand Milk Prod Co Ltd 乳由来オリゴ糖画分
AU2000267883A1 (en) * 2000-08-17 2002-02-25 Regen Therapeutics Plc Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
KR100423708B1 (ko) 2000-09-27 2004-03-24 주식회사 한국메디칼푸드 초유 분획을 유효성분으로 하는 면역증강제, 이의제조방법 및 용도

Also Published As

Publication number Publication date
US20090234099A1 (en) 2009-09-17
EP1894943A3 (en) 2008-05-28
IL170782A (en) 2012-02-29
EP1894943A2 (en) 2008-03-05
ATE380825T1 (de) 2007-12-15
KR20050123104A (ko) 2005-12-29
JP2007527368A (ja) 2007-09-27
EP1613648A1 (en) 2006-01-11
EP1613648B1 (en) 2007-12-12
CY1107195T1 (el) 2012-11-21
US20070161780A1 (en) 2007-07-12
WO2004081038A1 (en) 2004-09-23
US8168585B2 (en) 2012-05-01
ES2297398T3 (es) 2008-05-01
KR101089704B1 (ko) 2011-12-07
DE602004010636T2 (de) 2008-12-11
DE602004010636D1 (de) 2008-01-24
CA2518762A1 (en) 2004-09-23
AU2004220313B2 (en) 2011-06-02
AU2004220313A1 (en) 2004-09-23
NZ542383A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
IL182716A (en) Method for purifying recombinant fsh
CY1107195T1 (el) Καθαρισμος πεπτιδιων απο το πρωτογαλα
SI1685222T1 (sl) Postopek za pripravo sestavka, ki obsega polinenasičene spojine
WO2005000898A3 (en) Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
DE602006011099D1 (de) Verfahren zur herstellung von peptidderivaten
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
BRPI0417992A (pt) método para purificar fsh
WO2002057290A8 (en) Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
WO2008104308A3 (de) Verfahren zum abtrennen von stickstoff aus verflüssigtem erdgas
WO2005059149A3 (en) Improved protein production
SG155925A1 (en) Method for purifying and concentrating dinitrogen monoxide
WO2004039834A3 (en) Recombinant protein variants
PL1680150T3 (pl) Materiał kompozytowy zawierający hydrożel, wytworzony drogą elektrycznie wywołanego strącania fazy stałej
EA200300498A1 (ru) Способ получения бензина из углеводородного газового сырья
MXPA05008920A (es) Purificacion de 1,3-propandiol mediante destilacion.
WO2004106363A3 (en) A tag for purification of peptides
WO2005051985A3 (en) Methods for purifying pertussis toxin and peptides useful therefor
UA87709C2 (ru) Способ очищения фолликулостимулирующего гормона
EP1599578A4 (en) METHODS FOR PREVENTING GLYCONOYLATION OF PROTEINS
WO2003071425A3 (en) Process for the preparation of 1-(2,6,6-trimethyl-2-cyclohexene-1-yl)-but-2-ene-1-one
MXPA03011712A (es) Proceso para aislamiento de bisaril-triazinas monofenolicas.
IL178228A (en) Process for the semisynthesis of deserpidine
PT1644401E (pt) Acesso melhorado para síntese em fase suportada
WO2002070699A3 (en) Cofactors of the estrogen receptor alpha and methods of use
AU2003250932A1 (en) Method for producing macrocyclic ketones by means of dieckmann condensation in the gas phase